Functional expression of a biologically active fragment of soluble gp130 as an ELP-fusion protein in transgenic plants: Purification via inverse transition cycling

Biochemical Journal

Volumn 398, Issue 3, 2006, Pages 577-583

  Lin, Meng ^a   Rose John, Stefan ^a   Grötzinger, Joachim ^a   Conrad, Udo ^b   Scheller, Jürgen ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b LEIBNIZ INSTITUTE OF PLANT GENETICS AND CROP PLANT RESEARCH IPK   (Germany)

Author keywords

Cytokine; Elastin like peptide (ELP); Glycoprotein 130 (GP130); Interleukin 6 (IL 6); Inverse transition cycling; Tobacco

Indexed keywords

CYTOKINE; ELASTIN LIKE PEPTIDE (ELP); GLYCOPROTEIN 130 (GP130); INTERLEUKIN-6 (IL-6); INVERSE TRANSITION CYCLING;

AMINO ACIDS; PATHOLOGY; PROTEINS; TOBACCO; TUMORS;

PLANTS (BOTANY);

CYTOKINE; ELASTIN; GLYCOPROTEIN GP 130; HYBRID PROTEIN; IMMUNOGLOBULIN G; INTERLEUKIN 6; STAT3 PROTEIN; PEPTIDE FRAGMENT;

ARTICLE; CELL PROLIFERATION; HEPATOMA CELL; HUMAN; HUMAN CELL; PLANT MORPHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PURIFICATION; SIGNAL TRANSDUCTION; TOBACCO; TRANSGENIC PLANT; ANIMAL; CELL LINE; CHEMISTRY; GENE EXPRESSION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MOUSE; PLANT LEAF; SOLUBILITY;

AMINO ACIDS; PATHOLOGY; PLANTS; TOBACCO; TUMORS;

MURINAE; NICOTIANA OBTUSIFOLIA; NICOTIANA TABACUM;

ANIMALS; CELL LINE; CYTOKINE RECEPTOR GP130; GENE EXPRESSION; HUMANS; INTERLEUKIN-6; MICE; PEPTIDE FRAGMENTS; PLANT LEAVES; PLANTS, GENETICALLY MODIFIED; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION; SOLUBILITY; TOBACCO;

EID: 33748747042     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20060544     Document Type: Article

References (49)

1. Heinrich, P. C., Behrmann, I., Muller-Newen, G., Schaper, F. and Graeve, L. (1998) Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem. J. 334, 297-314
2. Jones, S. and Rose-John, S. (2002) The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex. Biochim. Biophys. Acta 1592, 251-264
3. Rose-John, S. (2001) Coordination of interleukin-6 biology by membrane bound and soluble receptors. Adv. Exp. Med. Biol. 495, 145-151
4. Lust, J. A., Donovan, K. A., Kline, M. P., Greipp, P. R., Kyle, R. A. and Maihle, N. J. (1992) Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 4, 96-100
5. Rose-John, S. and Heinrich, P. C. (1994) Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300, 281-290
6. Müllberg, J., Althoff, K., Jostock, T. and Rose-John, S. (2000) The importance of shedding of membrane proteins for cytokine biology. Eur. Cytokine Netw. 11, 27-38
7. Althoff, K., Reddy, P., Peschon, J., Voltz, N., Rose-John, S. and Müllberg, J. (2000) Contribution of the amino acid sequence at the cleavage site to the cleavage pattern of transmembrane proteins. Eur. J. Biochem. 267, 2624-2631
8. Althoff, K., Müllberg, J., Aasland, D., Voltz, N., Kallen, K.-J., Grötzinger, J. and Rose-John, S. (2001) Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins. Biochem. J. 353, 663-672
9. Hundhausen, C., Misztela, D., Berkhout, T. A., Broadway, N., Saftig, P., Reiss, K., Hartmann, D., Fahrenholz, F., Postina, R., Matthews, V. et al. (2003) The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-tell adhesion. Blood 102, 1186-1195
10. Matthews, V., Schuster, B., Schütze, S., Kallen, K.-J. and Rose-John, S. (2003) Cholesterol depletion of the plasma membrane triggers shedding of the human interleukin-6 receptor by TACE and independently of PKC. J. Biol. Chem. 278, 38829-38839
11. Abel, S., Hundhausen, C., Mentlein, R., Schulte, A., Berkhout, T. A., Broadway, N., Hartmann, D., Sedlacek, R., Dietrich, S., Muetze, B. et al. (2004) The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10. J. Immunol. 172, 6362-6372
12. Mackiewicz, A., Schooltink, H., Heinrich, P. C. and Rose-John, S. (1992) Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins. J. Immunol. 149, 2021-2027
13. Taga, T., Hibi, M., Hirata, Y., Yamasaki, K., Yasukawa, K., Matsuda, T., Hirano, T. and Kishimoto, T. (1989) Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 58, 573-581
14. Jones, S. A., Richards, P. J., Scheller, J. and Rose-John, S. (2005) IL-6 transsignaling: the in vivo consequences. J. Interferon Cytokine Res. 25, 241-253
15. Hui, W., Bell, M. and Carroll, G. (2000) Soluble glycoprotein 130 (gp130) attenuates OSM- and LIF-induced cartilage proteoglycan catabolism. Cytokine 12, 151-155
16. Jostock, T., Müllberg, J., Özbek, S., Atreya, R., Blinn, G., Voltz, N., Fischer, M., Neurath, M. F. and Rose-John, S. (2001) Soluble gp130 is the natural inhibitor of soluble IL-6R transsignaling responses. Eur. J. Biochem. 268, 160-167
17. Scheller, J., Schuster, B., Holscher, C., Yoshimoto, T. and Rose-John, S. (2005) No inhibition of IL-27 signaling by soluble gp130. Biochem. Biophys. Res. Commun. 326, 724-728
18. Atreya, R., Mudter, J., Finotto, S., Müllberg, J., Jostock, T., Wirtz, S., Schütz, M., Bartsch, B., Holtmann, M., Becker, C. et al. (2000) Blockade of IL-6 transsignaling abrogates established experimental colitis in mice by suppression of the antiapoptotic resistance of lamina propria T cells. Nat. Med. 6, 583-588
19. Nowell, M. A., Richards, P. J., Horiuchi, S., Yamamoto, N., Rose-John, S., Topley, N., Williams, A. S. and Jones, S. A. (2003) Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130. J. Immunol. 171, 3202-3209
20. Becker, C., Fantini, M. C., Schramm, C., Lehr, H. A., Wirtz, S., Nikolaev, A., Burg, J., Strand, S., Kiesslich, R., Huber, S. et al. (2004) TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity 21, 491-501
21. Becker, C., Fantini, M. C., Wirtz, S., Nikolaev, A., Lehr, H. A., Galle, P. R., Rose-John, S. and Neurath, M. F. (2005) IL-6 signaling promotes tumor growth in colorectal cancer. Cell Cycle 4, 217-220
22. Hiatt, A., Cafferkey, R. and Bowdish, K. (1989) Production of antibodies in transgenic plants. Nature (London) 342, 76-78
23. Schillberg, S., Fischer, R. and Emans, N. (2003) Molecular farming of recombinant antibodies in plants. Cell. Mol. Life Sci. 60, 433-445
24. Ma, J. K.-C., Drake, P. and Christou, P. (2003) The production of pharmaceutical proteins in plants. Nat. Rev. Genet. 4, 794-805
25. Artsaenko, O., Peisker, M., zur Nieden, U., Fiedler, U., Weiler, E. W., Muntz, K. and Conrad, U. (1995) Expression of a single-chain Fv antibody against abscisic acid creates a wilty phenotype in transgenic tobacco. Plant J. 8, 745-750
26. Scheller, J., Henggeler, D., Viviani, A. and Conrad, U. (2004) Purification of spider silk-elastin from transgenic plants and application for human chondrocyte proliferation. Transgenic Res. 13, 51-57
27. Scheller, J., Leps, M. and Conrad, U. (2006) Forcing single-chain variable fragment production in tobacco seeds by fusion to elastin-like polypeptides. Plant. Biotech. J. 4, 243-247
28. Scheller, J. and Conrad, U. (2005) Plant-based material, protein and biodegradable plastic. Curr. Opin. Plant Biol. 8, 188-196
29. Fischer, M., Goldschmitt, J., Peschel, C., Kallen, K. J., Brakenhoff, J. P. J., Wollmer, A., Grötzinger, J. and Rose-John, S. (1997) A designer cytokine with high activity on human hematopoietic progenitor cells. Nat. Biotechnol. 15, 142-145
30. Vollmer, P., Oppmann, B., Voltz, N., Fischer, M. and Rose-John, S. (1999) A role for the immunoglobulin-like domain of the human IL-6 receptor: intracellular protein transport and shedding. Eur. J. Biochem. 263, 438-446
31. Xiang, C., Han, P., Lutziger, I., Wang, K. and Oliver, D. J. (1999) A mini binary vector series for plant transformation. Plant Mol. Biol. 40, 711-717
32. Bevan, M. (1984) Binary Agrobacterium vectors for plant transformation. Nucleic Acids Res. 12, 8711-8721
33. Zambriski, P., Joos, H., Gentello, J., Leemans, J., Van Montagu, M. and Schell, J. (1983) Ti-plasmid vector for introduction of DNA into plant cells without altering their normal regeneration capacity. EMBO J. 2, 2111-2123
34. Waxman, E., Rusinova, E., Hasselbacher, C. A., Schwartz, G. P., Laws, W. R. and Ross, J. B. (1993) Determination of the tryptophan:tyrosine ratio in proteins. Anal. Biochem. 210, 425-428
35. Reference deleted
36. Chow, D.-C., He, X.-L., Snow, A. L., Rose-John, S. and Garcia, K. C. (2001) Structure of an extracellular gp130-cytokine receptor signalling complex. Science 291, 2150-2155
37. Hammacher, A., Richardson, R. T., Layton, J. E., Smith, D. K., Angus, L. J., Hilton, D. J., Nicola, N. A., Wijdenes, J. and Simpson, R. J. (1998) The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factor. J. Biol. Chem. 273, 22701-22707
38. Hibi, M., Murakami, M., Saito, M., Hirano, T., Taga, T. and Kishimoto, T. (1990) Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 63, 1149-1157
39. Palacios, R. and Steinmetz, M. (1985) IL-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo. Cell 41, 727-734
40. Gearing, D. P., Ziegler, S. F., Comeau, M. R., Friend, D., Thoma, B., Cosman, D., Park, L. and Mosley, B. (1994) Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor. Proc. Natl. Acad. Sci. U.S.A. 91, 1119-1123
41. Horsten, U., Muller Newen, G., Gerhartz, C., Wollmer, A., Wijdenes, J., Heinrich, P. C. and Grotzinger, J. (1997) Molecular modeling-guided mutagenesis of the extracellular part of gp130 leads to the identification of contact sites in the interleukin-6 (IL-6).IL-6 receptor.gp130 complex. J. Biol. Chem. 272, 23748-23757
42. Scheller, J., Guhrs, K. H., Grosse, F. and Conrad, U. (2001) Production of spider silk proteins in tobacco and potato. Nat. Biotechnol. 19, 573-577
43. Artsaenko, O., Kettig, B., Fiedler, U., Conrad, U. and During, K. (1998) Potato tubers as a biofactory for recombinant antibodies. Mol. Breeding 4, 313-319
44. Larrick, J. W. and Thomas, D. W. (2001) Producing proteins in transgenic plants and animals. Curr. Opin. Biotechnol. 12, 411-418
45. Richter, L. J., Thanavala, Y., Arntzen, C. J. and Mason, H. S. (2001) Production of hepatitis B surface antigen in transgenic plants for oral immunization. Nat. Biotechnol. 18, 1167-1171
46. Daniell, H., Streatfield, S. J. and Wycoff, K. (2001) Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci. 6, 219-226
47. Giese, B., Roderburg, C., Sommerauer, M., Wortmann, S. B., Metz, S., Heinrich, P. C. and Muller-Newen, G. (2005) Dimerization of the cytokine receptors gp130 and LIFR analysed in single cells. J. Cell Sci. 118, 5129-5140
48. Tanaka, M., Kishimura, M., Ozaki, S., Osakada, F., Hashimoto, H., Okubo, M., Murakami, M. and Naka, K. (2001) Cloning of novel soluble gp130 and detection of its neutralizing autoantibodies in rheumatoid arthritis. J. Clin. Invest. 106, 137-144
49. Richards, P. J., Nowell, M. A., Horiuchi, S., McLoughlin, R. M., Fielding, C. A., Grau, S., Yamamoto, N., Ehrmann, M., Rose-John, S., Williams, A. S. et al. (2006) Functional characterization of a soluble gp130 isoform and its therapeutic capacity in an experimental model of inflammatory arthritis. Arthritis Rheum. 54, 1662-1672